Evaluation of a Parent/Child Cognitive-Behaviorial Therapy Program in ADHD Children With Emotional Dysregulation Profile (DP-KID)

January 20, 2023 updated by: University Hospital, Montpellier

Evaluation of a Parent/Child Cognitive-Behaviorial Therapy Program in ADHD Children With Emotional Dysregulation Profile : a Study Prospective, Controlled and Randomized

Attention Deficit Disorder (ADD) with or without Hyperactivity/Impulsivity (ADHD) is a neurodevelopmental syndrome that has a lasting impact on the child's daily lifestyle and leads to functional impairment. ADHD is recognized as the most common psychiatry disorder in children and it's considered as a public health problem.

ADHD is frequently associated with a new diagnostic entity " Disruptive Disorder with Emotional dysregulation ". This disorder is characterized by crisis of anger with verbal or physical aggression, intensity disproportionate to the context and developmental age.

Few studies have examined the elements of emotional dysregulation in ADHD in children. Many studies have shown the interest of CBT in multimodal management of ADHD symptoms and associated disorders.

The main objective is to evaluate the effectiveness of a Cognitive-Behavioral Therapy Parent/Child program versus a body mediation focused on emotional and behaviorial aspects in ADD children aged 7-13 years with dimensional emotional dysregulation at 6 months after intervention. Secondary objectives are to evaluate the impact of this program, at short-term (at the end of CBT) and at 6 months after intervention, on socio-communicative capacities, quality of life, children's functioning and parental stress.

It's a biomedical research, prospective, controlled, randomized, monocentric, two parallels, with an evaluation of the criteria of blind judgment.

Study Overview

Detailed Description

68 patients (parents and children) will be recruited within Montpellier University Hospital. They will be divided into a CBT group and a control group (body mediation).

The CBT group benefits from an intervention based on the program "Better manage its anger and its frustrations" of 15 sessions for the children.

The control group participates in an intervention of body mediation (theatre) of 15 session for the children.

The parents of CBT and Control groups participate in an CBT intervention of 8 sessions every 15 days.

Study Type

Interventional

Enrollment (Anticipated)

92

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

7 years to 13 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Children and adolescents aged 7-13 years ;
  • Children with a diagnostic of ADHD (diagnostics criteria from DSM-V);
  • Score CBCL-DP ≥ 180 (" Aggressive behavior ", " Anxious-depression " and " Attention problems ") ;
  • Children follow-up in Montpellier University Hospital ;
  • Parents and children benefit of social security.

Exclusion Criteria:

  • Children with a developmental delay or severe language disorder ;
  • Families non-french speaking ;
  • Absence of consent signed by parents and child ;
  • Children not living with at least one parent.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: CBT Group

The CBT group benefits of an intervention based on the program "Better manage its anger and its frustrations" of 15 sessions for the children.

Parents participate in an CBT intervention of 8 sessions every 15 days. The session allow to develop adapted behaviors, to manage the disruptive behaviors and to improve the relations parents/children.

Cognitive Behaviorial Therapy (CBT)
Sham Comparator: Control Group

The control group participates in an intervention of body mediation (theatre) of 15 session for the children.

Parents participate in an CBT intervention of 8 sessions every 15 days. The session allow to develop adapted behaviors, to manage the disruptive behaviors and to improve the relations parents/children.

Body mediation (theatre)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Variation between the initial assessment and the month evaluation atfer the end of the intervention on the score of the " Aggressive behavior " subscale at the CBCL (Child Behavior Checklist)
Time Frame: Evaluation at inclusion, 6 months and 12 months
The Questionnaire is completed by parents
Evaluation at inclusion, 6 months and 12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
:* Variation of total score on CBCL and score on " Dysregulation profile " (CBCL-DP) on Child Behavior Checklist
Time Frame: Evaluation at inclusion, 6 months and 12 months
The Questionnaire is completed by parents
Evaluation at inclusion, 6 months and 12 months
Variation of scores on " Strengths and Difficulties Questionnaire "
Time Frame: Evaluation at inclusion, 6 months and 12 months
Description: The Questionnaire is completed by parents and teachers
Evaluation at inclusion, 6 months and 12 months
Variation of scores on " Parenting Stress Index "
Time Frame: Evaluation at inclusion, 6 months and 12 months
The Questionnaire is completed by parents
Evaluation at inclusion, 6 months and 12 months
Variation of score on " Beck Depression Inventory "
Time Frame: Evaluation at inclusion, 6 months and 12 months
The Questionnaire is completed by parents
Evaluation at inclusion, 6 months and 12 months
Variation of scores on " Kidscreen-27 "
Time Frame: Evaluation at inclusion, 6 months and 12 months
The Questionnaire is completed by parents
Evaluation at inclusion, 6 months and 12 months
Variation of score on " PAR-ENT-Qol "
Time Frame: Evaluation at inclusion, 6 months and 12 months
The Questionnaire is completed by parents
Evaluation at inclusion, 6 months and 12 months
Variation of score on " Children's Global Assessment Scale " (C-GAS)
Time Frame: Evaluation at inclusion, 6 months and 12 months
The Questionnaire is completed by the evaluator who receive parents and their child.
Evaluation at inclusion, 6 months and 12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Elodie COURTABESSIS, MD PHD, University Hospital, Montpellier

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 28, 2017

Primary Completion (Anticipated)

March 28, 2024

Study Completion (Anticipated)

March 28, 2025

Study Registration Dates

First Submitted

May 30, 2017

First Submitted That Met QC Criteria

June 2, 2017

First Posted (Actual)

June 5, 2017

Study Record Updates

Last Update Posted (Actual)

January 23, 2023

Last Update Submitted That Met QC Criteria

January 20, 2023

Last Verified

January 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Attention Deficit Disorder With Hyperactivity

Clinical Trials on Cognitive Behavorial Therapy (CBT)

Subscribe